首页 | 本学科首页   官方微博 | 高级检索  
检索        

尿毒症血清诱导的磷酸钙晶体对人主动脉平滑肌细胞的钙化作用
引用本文:刘曜蓉,方炜,张琳,林爱武,倪兆慧,钱家麒.尿毒症血清诱导的磷酸钙晶体对人主动脉平滑肌细胞的钙化作用[J].中华肾脏病杂志,2013,29(5):364-369.
作者姓名:刘曜蓉  方炜  张琳  林爱武  倪兆慧  钱家麒
作者单位:200127,上海交通大学医学院附属仁济医院肾脏科 上海市腹膜透析研究中心分子细胞(肾病)实验室
摘    要:目的 探讨尿毒症患者血清诱导的磷酸钙晶体对人主动脉平滑肌细胞(HASMCs)钙化的影响.方法 尿毒症患者血清在37℃下孵育3d,超速离心法从尿毒症血清中分离磷酸钙晶体和无晶体血清,采用扫描电子显微镜和能量色散X射线光谱仪分析晶体的形态及化学特征.体外培养HASMCs,分为以下4组:对照组、尿毒症血清组、磷酸钙晶体组和无晶体血清组.茜素红染色及甲氧酚酞络合酮法检测HASMCs钙化结节的形成及细胞内钙含量.实时荧光定量PCR法检测骨形态发生蛋白2(BMP-2)、骨桥蛋白(OPN)、核结合因子α1亚基(Cbfα1)、碱性磷酸酶(ALP)、基质γ羧基谷氨酸蛋白(MGP)的mRNA表达.Cbfα1、OPN和BMP-2的蛋白表达用Westcrn印迹和ELISA法检测.结果 尿毒症血清可诱导磷酸钙晶体形成.与对照组相比,尿毒症血清明显促进HASMCs钙化结节形成,增加细胞内钙含量(P<0.05),并上调细胞BMP-2、OPN、Cbfα1的mRNA和蛋白表达(均P< 0.01);而磷酸钙晶体亦促进HASMCs钙化结节的形成,增加细胞内钙含量(P<0.05),上调BMP-2、OPN、Cbfα1的mRNA和蛋白表达(均P<0.01).无晶体血清组的HASMCs胞内钙含量和上述成骨蛋白的表达与对照组差异无统计学意义(均P> 0.05).结论 尿毒症血清可能通过诱导磷酸钙晶体的形成促进血管钙化的发生.

关 键 词:尿毒症  磷酸钙类  钙质沉着症  血清  人主动脉平滑肌细胞

Effect of calcium phosphate crystals induced by uremic serum on calcification of human aortic smooth muscle cells
LIU Yao-rong , FANG Wei , ZHANG Lin , LIN Ai-wu , NI Zhao-hui , QIAN Jia-qi.Effect of calcium phosphate crystals induced by uremic serum on calcification of human aortic smooth muscle cells[J].Chinese Journal of Nephrology,2013,29(5):364-369.
Authors:LIU Yao-rong  FANG Wei  ZHANG Lin  LIN Ai-wu  NI Zhao-hui  QIAN Jia-qi
Institution:Renal Division, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai Center for Peritoneal Dialysis Research, Molecular Cell Lab for Kidney Disease, Shanghai 200127, China; Corresponding author: FANG Wei, Email: fangwei _sh@126.com
Abstract:Objective To investigate the impact of calcium phosphate crystals induced by uremic serum on calcification of human aortic smooth muscle cells (HASMCs). Methods Uremic serum was incubated at 37℃ for 3 days. Calcium phosphate crystals and uremic supernatant were isolated from uremic serum by ultracentrifugation. Scanning electron microscope (SEM) and energy dispersive X - ray spectroscopy (EDX) were performed for analysis of morphological and chemical characteristics of the crystals. HASMCs were treated in vitro with control medium, uremic serum - medium, calcium phosphate crystals - medium and uremic supernatant - medium. Calcification was visualized by Alizarin red staining. Calcium loads in cells were quantified by o - cresolphthalein complexone method. Gene expression of bone morphogenetic protein-2 (BMP-2), osteopontin (OPN) and core-binding factor α1 (Cbfα1), alkaline phosphate (ALP) and matrix gamma carboxyglutamic acid protein (MGP) were quantified by real - time PCR. Cbfα1, OPN and BMP - 2 protein levels were determined by Western blotting or ELISA. Results Calcium phosphate crystals which induced by uremic serum displayed laminated shapes containing crystallized needle- like projections and ranged from 30 - 500 nm, with Ca/P ratios of 1.41±0.05. Compared with the cells in control group, uremic serum induced HASMCs calcification,increased calcium loads (P<0.05), up-regulated BMP-2, OPN , Cbfα1 mRNA and protein expression (all P<0.01). Similar to uremic serum, calcium phosphate crystals also induced HASMCs calcification, increased calcium loads (P<0.05), and up-regulated BMP-2, OPN , Cbfα1 mRNA and protein expression (all P<0.01). However, there was no significant difference between HASMCs growing in uremic supernatant and control medium in calcium loads or the expression levels of these osteogenic proteins (P>0.05). Conclusions Calcium phosphate crystals induced by uremic serum promote HASMCs calcification, which might be one of the mechanisms of uremic vascular calcification.
Keywords:Uremia  Calcium phosphates  Calcinosis  Serum  Human aortic smooth muscle cells
本文献已被 万方数据 等数据库收录!
点击此处可从《中华肾脏病杂志》浏览原始摘要信息
点击此处可从《中华肾脏病杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号